Malignant mast cell neoplasm Completed Phase 1 Trials for Sunitinib (DB01268)

Also known as: Malignant Mast Cell Tumors / Mast Cell Leukemia (MCL) / Leukemia, Mast Cell / Mast Cell Leukemia / Malignant-mast cell tumours / Mast-Cell Sarcoma

IndicationStatusPhase
DBCOND0007107 (Malignant mast cell neoplasm)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00890747Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyTreatment